Recently, two reviews highlighted the association between single selenoproteins and either colorectal or prostate cancer initiation and progression, as well as patient outcome, suggesting that these proteins could represent potential biomarkers or therapeutic targets [11,12]. This evidence concerns the gene SELENOS and Familial prostate cancer.